EPO and anemia (phenotype): While RBC transfusions remain useful to treat acute or severe symptomatic anaemia, distinguishing IDA from other causes is essential to guide subsequent therapeutics (e.g., iron supplementation/infusion, erythropoietin, etc.)[36, 37, 38], potentially reducing reliance on allogeneic RBCs and promoting patient blood management best practices.